XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 6 August 2020
Asset Under Management 247.05 Million (USD)
1 Month Total Return 1.53 %
Year To Date Return -2.26 %
1 Year Total Return 21.86 %
3 Year Annualized Total Return 3.14 %
NAV 44.5109
Share Outstanding 5,550,270
Top 10 Holdings (5 August 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
HORIZON THERAPEUTICS PLC HZNP EQUI 0.0682777500
CATALENT INC CTLT EQUI 0.0530518900
Zoetis Inc. Class A ZTS EQUI 0.0484476300
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0480914100
ELANCO ANIMAL HEALTH INC ELAN EQUI 0.0471734600
PFIZER INC PFE EQUI 0.0469174900
ELI LILLY & CO LLY EQUI 0.0442794500
MERCK & CO. INC. MRK EQUI 0.0440652200
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0437637600
MYLAN NV MYL EQUI 0.0436626600